Bayer AG
Bayer AG (Germany) holds 28 active US FDA Type II Drug Master Files and 24 inactive, has DMF or CEP filings on record for 38 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 4 FDA-registered manufacturing sites. 19 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Bayer AG: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/bayer-ag
Overview
Bayer AG is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. As a leading pharmaceutical company, Bayer develops and manufactures a wide range of healthcare products. Nexavar, an anticancer drug, is developed under Bayer's pharmaceuticals division.
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Bayer AG holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Bayer AG holds 28 active (52 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MOLIDUSTAT SODIUM (MICRONIZED) DRUG SUBSTANCEActive2020-09-10
- AZELAIC ACID (A)Active2014-06-26
- RIVAROXABAN (MICRONIZED) DRUG SUBSTANCEActive2008-07-23
- RIVAROXABAN COATED TABLETS, 10 MGActive2008-07-23
- EOB-DTPAActive2007-05-14
- NORGESTRELActive2004-04-16
- ILOPROSTActive2004-02-18
- TESTOSTERONE UNDECANOATE 750 MG I.M.Active2003-08-15
- TESTOSTERONE UNDECANOATEActive2003-08-15
- TESTOSTERONEActive2000-10-02
- ETHINYLESTRADIOL-BETA-CYCLODEXTRIN-CLATHRATEActive2000-07-25
- DIENOGESTActive1999-02-26
- GADOBUTROLActive1998-07-07
- DROSPIRENONEActive1996-09-09
- CIPROFLOXACIN HYDRATED DRUG SUBSTANCEActive1993-07-13
- AZELAIC ACIDActive1991-08-07
- CIPROFLOXACINActive1991-02-28
- ACARBOSEActive1990-04-23
- IOPROMIDEActive1989-08-15
- CIPROFLOXACIN HYDROCHLORIDEActive1989-07-14
- MEDROXYPROGESTERONE ACETATEActive1984-05-11
- ESTRADIOLActive1982-10-13
- LEVONORGESTRELActive1981-05-21
- ESTRADIOL VALERATEActive1978-11-02
- TESTOSTERONE ENANTHATEActive1978-10-31
- NORETHINDRONEActive1976-08-05
- NORETHINDRONE ACETATEActive1972-12-22
- ETHINYLESTRADIOLActive1972-08-16
- NIFEDIPINE DRUG SUBSTANCEInactive2015-10-23
- NICLOSAMIDE ANHYDROUS DRUG SUBSTANCEInactive2011-10-06
- NICLOSAMIDE 500MG TABLETInactive2011-10-06
- MS-275Inactive2007-05-02
- ASPIRIN USPInactive2000-11-20
- AMPICILLIN TRIHYDRATEInactive1998-09-01
- AMPICILLINInactive1998-09-01
- ESTRONEInactive1994-08-01
- NISOLDIPINEInactive1993-03-31
- BAY Y 3118 DRUG SUBSTANCEInactive1992-09-08
- TRASYLOL (APROTININ) DRUG PRODUCTInactive1992-08-14
- METRIFONATE DRUG PRODUCTInactive1991-06-14
- METRIFONATE DRUG SUBSTANCEInactive1991-06-14
- FACILITY AND OPERATING PROCEDURES IN DORMAGEN, WEST GERMANYInactive1989-10-20
- AMPICILLIN SODIUM STERILEInactive1989-06-15
- ACEMETACINInactive1989-01-09
- CLOTRIMAZOLEInactive1987-01-15
- FACILITIES AND PERSONNEL AT WUPPERTAL, WEST GERMANYInactive1986-06-02
- FACILITIES AND PERSONNEL IN LEVERKUSEN, GERMANYInactive1986-05-28
- MUZOLIMINE SEMIHYDRATEInactive1986-01-10
- EDRUL TABS (20,30 & 240MG)Inactive1986-01-10
- GESTODENEInactive1985-12-19
Showing the 50 most relevant of 52 Drug Master Files (active first). The full list is in the FDA DMF list.
Excipient Drug Master Files
Bayer AG holds 1 active (2 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- CALCOBUTROLActive1998-07-07
- BAYER PRODUCTS IN THE MAKROLON SERIESInactive1984-09-06
Registered manufacturing sites (4)
Physical sites registered with the US FDA and resolved to Bayer AG, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
19 FDA enforcement records linked to this company.
- 4832020-07-27
Control procedures to monitor and validate performance
- 4832020-07-27
Prevention of cross contamination, mix-ups
- 4832020-07-27
Written procedures fail to include
- 4832020-07-27
Scientifically sound laboratory controls
- 4832020-07-27
Written record of investigation incomplete
- 4832019-09-24
Cleaning System
- 4832019-09-24
Written procedures not established/followed
- 4832019-09-24
Top/Middle/Bottom container sampling
- 4832019-03-22
Following/documenting laboratory controls
- 4832019-03-22
Labels and labeling stored separately
- 4832019-03-22
Written procedures fail to include
- 4832019-03-22
Identification of containers, lines, equipment
- 4832019-03-22
Prepared for each batch, include complete information
- 4832019-03-22
Control procedures to monitor and validate performance
- warning_letter2017-11-14
FDA Warning Letter (drug product)
- 4832014-05-13
Scientifically sound laboratory controls
- 4832014-05-13
Written record of investigation incomplete
- 4832014-05-13
Extent of discrepancy, failure investigations
- warning_letter2009-08-05
FDA Warning Letter (drug product)
Is this Bayer AG?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.